Showing 96-100 of 149 news & articles:
OM1 Launches New Mental Health and Neuroscience Real-World Data Network

Read the Press Release>>   BOSTON, March 31, 2022 /PRNewswire/ — OM1, a leading technology enabled real-world data and artificial intelligence (AI) company with a focus on delivering insights into multiple chronic diseases, today announces the launch of its Mental Health and Neuroscience Specialty Area led by physician and entrepreneur, Dr. Carl D. Marci. The division includes new data on psychiatric[…]

Real-World Data Delivers Dose of Hope for Mental Health in the U.S.

Pharmaceutical Executive Online Published: March 15, 2022 Read the Full Article >> If you were asked which health care conditions rank as the highest in both unmet need and in cost, which would you choose? Would it be cancer or heart disease? While those conditions certainly place in both categories, mental health outranks them in[…]

Real-World Data + AI: Bridging the Gap from Population to Personalization

Inside Precision Medicine Online Published: February 16, 2022 Read the Full Article >>   Personalizing medicine using population-level insights can seem like a contradiction. On one hand, the goal is to better fit treatment to the individual patient, moving away from generalized approaches toward a “one size fits all” model.  On the other, we have[…]

Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder

BioMed Central Online Published: 14 February 2022 Read the Full Manuscript >> Background Many second-generation antipsychotics (SGAs) are associated with weight gain and cardiometabolic effects. Antipsychotic-associated weight gain is linked to treatment interruptions, potentially increasing risk of relapse and hospitalization. This retrospective study assessed clinically significant weight gain (CSWG), treatment interruptions, and development of cardiometabolic[…]